scholarly journals Alginate Hydrogels for Three-Dimensional Culture and Real-Time Monitoring of Cancer Cell Metabolism and Radiation Response

2017 ◽  
Vol 99 (2) ◽  
pp. S148
Author(s):  
A.H. Kesarwala ◽  
J.L. Carter ◽  
G.H. Read ◽  
N. Miura ◽  
K. Yamamoto ◽  
...  
Keyword(s):  
Real Time ◽  
Cancer Cell ◽  
Cell Metabolism ◽  
Three Dimensional ◽  
Radiation Response ◽  
Real Time Monitoring ◽  
Alginate Hydrogels ◽  
Cancer Cell Metabolism ◽  
Three Dimensional Culture

Real-Time Monitoring of Cancer Cell Metabolism and Effects of an Anticancer Agent using 2D In-Cell NMR Spectroscopy

2015 ◽  
Vol 127 (18) ◽  
pp. 5464-5467 ◽  
Author(s):  
He Wen ◽  
Yong Jin An ◽  
Wen Jun Xu ◽  
Keon Wook Kang ◽  
Sunghyouk Park
Keyword(s):  
Nmr Spectroscopy ◽  
Real Time ◽  
Cancer Cell ◽  
Anticancer Agent ◽  
Cell Metabolism ◽  
Real Time Monitoring ◽  
Cancer Cell Metabolism

scholarly journals A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4)

2021 ◽  
Vol 22 (6) ◽  
pp. 2918
Author(s):  
Eleni Papakonstantinou ◽  
Dimitrios Vlachakis ◽  
Trias Thireou ◽  
Panayiotis G. Vlachoyiannopoulos ◽  
Elias Eliopoulos
Keyword(s):  
Cancer Cell ◽  
Structural Characteristics ◽  
Cell Metabolism ◽  
Intracellular Localization ◽  
Selective Inhibition ◽  
Monocarboxylate Transporter ◽  
Cancer Drug ◽  
Pharmacophore Modelling ◽  
Anti Cancer ◽  
Cancer Cell Metabolism

Monocarboxylate transporters (MCTs) are of great research interest for their role in cancer cell metabolism and their potential ability to transport pharmacologically relevant compounds across the membrane. Each member of the MCT family could potentially provide novel therapeutic approaches to various diseases. The major differences among MCTs are related to each of their specific metabolic roles, their relative substrate and inhibitor affinities, the regulation of their expression, their intracellular localization, and their tissue distribution. MCT4 is the main mediator for the efflux of L-lactate produced in the cell. Thus, MCT4 maintains the glycolytic phenotype of the cancer cell by supplying the molecular resources for tumor cell proliferation and promotes the acidification of the extracellular microenvironment from the co-transport of protons. A promising therapeutic strategy in anti-cancer drug design is the selective inhibition of MCT4 for the glycolytic suppression of solid tumors. A small number of studies indicate molecules for dual inhibition of MCT1 and MCT4; however, no selective inhibitor with high-affinity for MCT4 has been identified. In this study, we attempt to approach the structural characteristics of MCT4 through an in silico pipeline for molecular modelling and pharmacophore elucidation towards the identification of specific inhibitors as a novel anti-cancer strategy.

scholarly journals Oncolytic Virotherapy: The Cancer Cell Side

Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 939
Author(s):  
Marcelo Ehrlich ◽  
Eran Bacharach
Keyword(s):  
Viral Replication ◽  
Cancer Cell ◽  
Cell Metabolism ◽  
Tumor Development ◽  
Oncolytic Viruses ◽  
Oncogenic Signaling ◽  
Functional Connection ◽  
Immunity Genes ◽  
Cancer Cell Metabolism ◽  
Editing Process

Cell autonomous immunity genes mediate the multiple stages of anti-viral defenses, including recognition of invading pathogens, inhibition of viral replication, reprogramming of cellular metabolism, programmed-cell-death, paracrine induction of antiviral state, and activation of immunostimulatory inflammation. In tumor development and/or immunotherapy settings, selective pressure applied by the immune system results in tumor immunoediting, a reduction in the immunostimulatory potential of the cancer cell. This editing process comprises the reduced expression and/or function of cell autonomous immunity genes, allowing for immune-evasion of the tumor while concomitantly attenuating anti-viral defenses. Combined with the oncogene-enhanced anabolic nature of cancer-cell metabolism, this attenuation of antiviral defenses contributes to viral replication and to the selectivity of oncolytic viruses (OVs) towards malignant cells. Here, we review the manners by which oncogene-mediated transformation and tumor immunoediting combine to alter the intracellular milieu of tumor cells, for the benefit of OV replication. We also explore the functional connection between oncogenic signaling and epigenetic silencing, and the way by which restriction of such silencing results in immune activation. Together, the picture that emerges is one in which OVs and epigenetic modifiers are part of a growing therapeutic toolbox that employs activation of anti-tumor immunity for cancer therapy.

scholarly journals Real-time monitoring in three-dimensional hepatocytes reveals that insulin acts as a synchronizer for liver clock

2012 ◽  
Vol 2 (1) ◽  
Author(s):  
Daisuke Yamajuku ◽  
Takahiko Inagaki ◽  
Tomonori Haruma ◽  
Shingo Okubo ◽  
Yutaro Kataoka ◽  
...  
Keyword(s):  
Real Time ◽  
Three Dimensional ◽  
Real Time Monitoring

AVB-500, a selective inhibitor of GAS6-AXL, in combination with paclitaxel alters uterine serous cancer cell metabolism

2021 ◽  
Vol 162 ◽  
pp. S97
Author(s):  
Shaina Bruce ◽  
Kevin Cho ◽  
Elena Lomonosova ◽  
Hollie Noia ◽  
Elizabeth Stock ◽  
...  
Keyword(s):  
Cancer Cell ◽  
Cell Metabolism ◽  
Selective Inhibitor ◽  
Cancer Cell Metabolism
Sign in / Sign up

Export Citation Format

Share Document